GSA CAPITAL PARTNERS LLP - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$404,000
+2.3%
27,000
-16.8%
0.02%
-12.0%
Q1 2016$395,000
-11.2%
32,461
+16.1%
0.02%
+13.6%
Q4 2015$445,000
-56.4%
27,960
-36.3%
0.02%
-46.3%
Q1 2015$1,021,000
+228.3%
43,904
+265.3%
0.04%
+192.9%
Q2 2014$311,000
+15.2%
12,018
+13.1%
0.01%
-33.3%
Q4 2013$270,00010,6270.02%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders